Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg.
⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines, such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose of 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose).
⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose of 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin.
When this medicine is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions).
This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin.
If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose.
Patients with renal impairment
No dose adjustment is necessary in patients with mild renal impairment.
Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other symptoms that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with empagliflozin and metformin as separate single-ingredient medicines. The maximum daily dose of metformin hydrochloride that can be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily.
Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)).
If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)).
Elderly patients
In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.
Improvement of glycemic control in adults with type 2 diabetes mellitus
Type 2 diabetes
abnormal blood sugar control
cardiovascular disease
View approved original textHide original text
This medication is used to improve blood sugar control in adult patients with type 2 diabetes in conjunction with diet and exercise. It can be used in particularly careful circumstances for adult patients with type 2 diabetes who do not achieve sufficient blood sugar control and also have cardiovascular disease. It is designed to assist in managing blood sugar levels and may have a positive effect on cardiovascular health, making it important to take under the guidance of a healthcare professional for safe use.
How to take
Adult dose
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg.
⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines, such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose of 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose).
⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose of 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin.
When this medicine is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions).
This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin.
If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose.
Patients with renal impairment
No dose adjustment is necessary in patients with mild renal impairment.
Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other symptoms that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with empagliflozin and metformin as separate single-ingredient medicines. The maximum daily dose of metformin hydrochloride that can be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily.
Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)).
If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)).
Elderly patients
In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.
Precautions
This medication is used in the treatment of diabetes and helps lower blood sugar levels.
It can cause a rare but serious side effect known as lactic acidosis; therefore, it should not be used by patients with poor kidney function or certain acute diseases.
In addition, when used with other diabetes medications such as insulin or sulfonylureas, the risk of hypoglycemia may increase, so caution is advised.
Patients with weakened kidney function or the elderly should regularly undergo kidney function tests, and if kidney function declines significantly, the use of this medication should be discontinued.
During the use of this medication, if there is a sudden change in physical condition such as dehydration, severe infection, or surgery, it may be necessary to temporarily stop taking the medication.
This medication may cause urinary tract infections or genital infections, so if symptoms of infection appear, immediate consultation with medical personnel is required.
Gastrointestinal disturbances such as nausea, vomiting, and diarrhea may occur during use, and vitamin B12 deficiency may develop, so confirmation through blood tests may be necessary if needed.
Women who are pregnant, potentially pregnant, or breastfeeding should not take this medication.
Furthermore, alcohol consumption may increase the risk of side effects from this medication, so it is advisable to avoid it.
This medication can cause water loss and drop in blood pressure, so caution is needed, especially for hypertensive patients or the elderly.
If any unusual symptoms or suspected side effects occur during treatment, immediate consultation with a physician is recommended, and regular check-ups should be conducted for safe use.
Side effects
Hypoglycemia
urinary tract infection
genital infection
increased urination
decreased and deficiency of vitamin B12
ketoacidosis
lactic acidosis
decreased fluid volume
nausea
vomiting
Show 172 moreCollapse
diarrhea
abdominal pain
loss of appetite
constipation
abnormal liver function tests
hepatitis
dysgeusia
pruritus
rash
urticaria
erythema
angioedema
dysuria
interstitial nephritis
thirst
increased serum lipids
increased serum creatinine
decreased glomerular filtration rate
increased hematocrit
perineal necrosis
chronic gastritis
cerebral infarction
soft tissue infection
pneumonia
ankle fracture
epicondylitis
facial bone fracture
musculoskeletal pain
myocardial infarction
diarrhea
nausea
gastric ulcer
colitis
vomiting
ischemic colitis
gastrointestinal bleeding
appendiceal abscess
appendicitis
meningitis
chronic otitis media
peritonsillar abscess
pulmonary tuberculosis
acute pyelonephritis
sepsis
subcutaneous abscess
tubal-ovarian abscess
vestibular neuritis
headache
sensory loss
position-induced dizziness
dizziness
drowsiness
weakness
chest discomfort
chest pain
fever
facial swelling
chills
strange feeling
edema
pain
puncture site pain
vascular stent stenosis
vascular stent thrombosis
increased alanine aminotransferase
increased aspartate aminotransferase
weight loss
vulvar pruritus
benign prostatic hyperplasia
diabetic retinopathy
diplopia
hypertension
insomnia
nasopharyngitis
herpes zoster
cervical inflammation
hyperglycemia
hyponatremia
dermal cyst
seborrheic dermatitis
atopic dermatitis
diabetic foot
nummular eczema
heat rash
sebaceous gland hyperplasia
lumbar spinal stenosis
myalgia
limb pain
musculoskeletal chest pain
arthralgia
cervical stenosis
fibromyalgia
flank pain
fracture pain
muscle weakness
osteoarthritis
osteoporosis
rotator cuff syndrome
astigmatism
cataract
allergic conjunctivitis
blurred vision
corneal abrasion
glaucoma
macular fibrosis
eye discomfort
eye congestion
pathological myopia
retinal detachment
retinal deposits
retinal vein occlusion
proliferative retinal detachment
eyelid swelling
visual impairment
vitreous floaters
vitreous hemorrhage
epistaxis
asthma
age-related dyspnea
wet cough
allergic rhinitis
residual sputum
cough
skin laceration
contusion
rib fracture
concussion
corneal abrasion
falls
hand fracture
iliotibial band syndrome
open globe injury
pelvic fracture
road traffic accident
splenic injury
sternum fracture
angina
palpitations
Prinzmetal angina
coronary artery disease
tachycardia
arteriosclerosis
deep vein thrombosis
diabetic vascular complications
peripheral artery occlusive disease
anxiety
depression
sleep disorder
acute cholecystitis
autoimmune hepatitis
cholelithiasis
hepatitis
otalgia
postural vertigo
vertigo
anemia
lymphadenopathy
hypothyroidism
thyroid nodule
constipation
dyspepsia
abdominal pain
gastritis
gastrointestinal disorder
nasopharyngitis
herpes zoster
dizziness
chest discomfort
chest pain
weakness
vulvar pruritus
genital pruritus
Not everyone experiences these, and they can vary from person to person.
Storage
This medication is prone to be affected by air or moisture, so it must be stored in a tightly sealed container. The storage temperature should ideally be maintained at room temperature between 1 to 30 degrees Celsius.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.